xavier gocko

Dr. xavier gocko

Jean Monnet University, Saint-Étienne, Auvergne-Rhône-Alpes, France
orcid

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2019 in Medecine Et Maladies Infectieuses
Verified
Journal Article
Closed access
XGxavier gocko
xavier gocko
CLC. Lenormand
C. Lenormand
CLC. Lemogne
C. Lemogne
KBK. Bouiller
K. Bouiller
JGJ.-F. Gehanno
J.-F. Gehanno
PTP. Tattevin
P. Tattevin

22 June 2022 in Vaccines
Verified
Journal Article
Open access
PDF file
NPNatacha Pinatel
Natacha Pinatel
CPCatherine Plotton
Catherine Plotton
BPBruno Pozzetto
Bruno Pozzetto
XGxavier gocko
xavier gocko
Vaccine hesitancy (VH) is defined as “delaying or refusing a secure vaccine despite its availability”. This hesitancy affects caregivers and more specifically nurses. The purpose of this study is to assess determinants of influenza VH in the nurse’s community. We conducted a systematic review of qualitative literature according to criteria of Preferred Reporting Items for Systematic Review and Meta-Analysis and Enhancing Transparency in Reporting the synthesis of Qualitative Research from 2009 until October 2020. Eleven qualitative studies analysed (ten thematic content analyses and one grounded theory method) found three main factors in VH. The first determinant was the benefit–risk equation considered as unfavourable due to an ineffective vaccine and fears about adverse effects as the pain of the injection. Wrong immunological beliefs brought into hesitancy. Disease barriers (hand washing and masks) and personal immunity were regarded as more effective than the vaccine. Lastly, dehumanised vaccination and the difficulties of access to healthcare were institutional determinants. Nurses ask for a vaccine promotion by hierarchy and doctors with transparent information and respect for autonomy. The availability of vaccines and methods of pain control seem to be some tracks to reduce nurses’ VH.

1 February 2021 in Infectious Diseases Now
Verified
Journal Article
Closed access
XGxavier gocko
xavier gocko
PTP. Tattevin
P. Tattevin
CLCédric Lemogne
Cédric Lemogne

2 October 2023 in BMC Infectious Diseases
Verified
Journal Article
Open access
PDF file
PSPrat Sébastien
Prat Sébastien
DJDalbin Jacques
Dalbin Jacques
PCPlotton Catherine
Plotton Catherine
XGxavier gocko
xavier gocko
Background: Approximately 10% of patients experience prolonged symptoms after Lyme disease. PTLDS (post treatment Lyme disease syndrome) is a controversial topic. It has been described as a source of overdiagnosis and off-label treatment. This review aims to describe the diagnostic errors and adverse events associated with the diagnosis and treatment of PTLDS. Methods: systematic review of the literature in the Medline and Cochrane Library databases, according to PRISMA criteria, including randomized clinical trials (RCT), observational studies, and case reports addressing diagnostic errors and adverse events published between January 2010 and November 2020 in English or French. Selection used a quadruple reading process on the basis of the titles and abstracts of the different articles, followed by a full reading. Results: 17 studies were included: 1 RCT, 6 observational studies and 10 case reports. In the 6 observational studies, overdiagnosis rates were very high, ranging from 80 to 100%. The new diagnoses were often psychiatric, rheumatological and neurological. Disorders with somatic symptoms were often cited. Diagnostic delays were identified for cancers and frontoparietal dementia. In the RCT and observational studies, prolonged anti-infective treatments were also responsible for adverse events, with emergency room visits and/or hospitalization. The most common adverse events were diarrhea, sometimes with Clostridium difficile colitis, electrolyte abnormalities, sepsis, bacterial and fungal infections, and anaphylactic reactions. Conclusion: This review highlights the risks of prolonged anti-infective treatments that have not been proven to be beneficial in PTLDS. It emphasizes the ethical imperative of the “primum non nocere” principle, which underscores the importance of not causing harm to patients. Physicians should exercise caution in diagnosing PTLDS and consider the potential risks associated with off-label treatments.

25 November 2023 in The Breast
Verified
Journal Article
Open access
SHSandrine Hild
Sandrine Hild
DTDelphine Teigné
Delphine Teigné
DFDamien Fairier
Damien Fairier
YRYannick Ruelle
Yannick Ruelle
IAIsabelle Aubin-Auger
Isabelle Aubin-Auger
CRCédric Rat
Cédric Rat
And purpose: In France, women lack information to make a shared decision to start breast cancer screening. Decision aids are useful to facilitate this discussion, yet few meet international standards. The objective of this project was to build, validate and measure the quality of a decision aid for organized breast screening in France, in line with international standards, intended for both women and healthcare professionals. This mixed-methods study was conducted between January 2017 and June 2022. The prototype was developed from a qualitative study, systematic review and targeted literature review and alpha tested during two Delphi rounds. Readability was evaluated with the Flesch score and content with International Patient Decision Aid Standards Instrument (IPSASi). An online decision aid, accessible at www.Discutons-mammo.fr, written in French was developed. The content included eligibility, information about breast screening the advantages and disadvantages of screening, patient preferences and a patient-based discussion guide using text, infographics, and videos. The Flesch readability test score was 65.4 and the IPDASi construct quality score was 176 out of 188. This decision aid complies with IPDASi standards and could help women eligible for breast screening in France make a shared decision with a specialized healthcare professional about whether or not to participate in organized breast screening.

1 August 2019 in Vaccine
Verified
Journal Article
Closed access
XGxavier gocko
xavier gocko
SPSylvain Poulteau
Sylvain Poulteau
MBMarie-Noëlle Beyens
Marie-Noëlle Beyens
PBPierre Bertholon
Pierre Bertholon
BPBruno Pozzetto
Bruno Pozzetto